SOURCE-LINKED STUDY SUMMARY
Pharmacotherapy of obesity: an update on the available medications and drugs under investigation.
Full paper summarizedQuality not appraised
- What was studied
- Evidence review of approved anti-obesity medicines and investigational drugs, updating prior work with Medline and Embase searches.
- Who / model studied
- The review included 46 randomized trials and 8 systematic reviews or meta-analyses of adults with obesity, plus ongoing adult pipeline trials.
- Studied dose & schedule
- Dose and schedule have not yet been extracted for this summary.
- What the study found
- Available medicines improved weight and metabolic measures with differing potency. At the review date, evidence did not show reduced hard cardiovascular outcomes, and long-term mortality data remained scarce.
- Limitations & context
- Searches covered selected date windows and the pipeline search was updated through June 4, 2022. This synthesis is not one comparative trial, and the authors emphasized scarce long-term outcome evidence.
Read summary source ↗ · Prepared 9/22/2026 · AI-assisted, source-based summary
Review record & corrections
Summary prepared: . Source scope: full paper. This is an AI-assisted source summary, not an independent clinician sign-off.
No public field-by-field revision history is available for this card yet. The date above is the summary date, not proof that every field was updated then.
Inspect the source · Correction policyResearch findings apply to the population and conditions studied. This educational summary is not a treatment recommendation or a formal assessment of study quality.
Original publication ↗ · DOI: 10.1016/j.eclinm.2023.101882